MicroRNAs as biomarkers for prostate cancer prognosis: a systematic review and a systematic reanalysis of public data.

Rana, Sharmila; Valbuena, Gabriel N; Curry, Ed; Bevan, Charlotte L; Keun, Hector C

Rana, Sharmila; Valbuena, Gabriel N; Curry, Ed; Bevan, Charlotte L; Keun, Hector C.

Afiliação

Rana S; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK.
Valbuena GN; Wellcome Centre for Human Genetics, University of Oxford, Oxford, OX3 7BN, UK.
Curry E; GSK, Stevenage, SG1 2NY, UK.
Bevan CL; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK. charlotte.bevan@imperial.ac.uk.
Keun HC; Division of Cancer, Department of Surgery and Cancer, Imperial College London, London, W12 0NN, UK. h.keun@imperial.ac.uk.

Br J Cancer ; 126(3): 502-513, 2022 02.

Article em En | MEDLINE | ID: mdl-35022525

Assuntos

Biomarcadores Tumorais/genética; MicroRNAs/genética; Prostatectomia/métodos; Neoplasias da Próstata/patologia; Estudos de Coortes; Humanos; Masculino; Prognóstico; Neoplasias da Próstata/genética; Neoplasias da Próstata/cirurgia; Taxa de Sobrevida

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Prostatectomia / Neoplasias da Próstata / Biomarcadores Tumorais / MicroRNAs Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google